The U.S. Food and Drug Administration has approved Genentech's Susvimo (ranibizumab) 100 mg/mL for treating diabetic macular ...

Opthea Limited (NASDAQ:OPT), a biopharmaceutical company with a market capitalization of $894.5 million specializing in the ...

Opthea Limited (ASX/NASDAQ:OPT, “Opthea”, the “Company”), a clinical-stage biopharmaceutical company developing novel therapies to treat highly prevalent and progressive retinal diseases, including ...

This research team evaluated the effectiveness of switching patients to faricimab treatment by assessing their outcomes after ...

Australia has become the first country outside of the United States to approve the use of the drug pegcetacoplan (SYFOVRE) to slow down the progression of geographic atrophy.

Despite vision impairment and financial struggles, Rajesh Kumar, who worked as a security guard, transformed his life by venturing into rose farming — eventually building a thriving business selling ...

A new provision decreeing basic eye services will not be allowed to be billed on the same day as medically necessary eye care for children or seniors is expected to hit those with difficulties ...

Nearly every disease has an inflammatory component, but blood tests can't pinpoint inflammation in specific organs or tissues ...

A sight loss organisation’s services in Scotland have been awarded a cash boost of nearly £100,000 for the next three years.

Sun Hill Optical has been the trusted source for exceptional eye care in Hillsborough County. It was founded by Francis ...

For the quarter, the fund's Retail Class shares gained 8.15%, topping the 6.35% advance of the benchmark, the NASDAQ ...